Advancing Cell Therapy Manufacturing: Rapid Sterility Testing to Help Ensure the Safety and Quality of Cell Therapy Products

[Article Title]

Cell therapy products show great potential in regenerative medicine but are vulnerable to microbial contamination due to complex manufacturing processes. Traditional sterility testing requires a 14-day culture, delaying the release of time-sensitive therapies. USP chapter <1071> highlights rapid alternatives like qPCR, which enables microorganism detection within hours.

Download this application note to discover how the Applied Biosystems SteriSEQ Rapid Sterility Testing Kit, powered by TaqMan chemistry, delivers actionable sterility results in just 5 hours for fast and reliable cell therapy testing.

Download Document

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

  • Thermo Fisher Scientific is here to help you succeed in moving your biopharmaceutical analytics forward. Would you like to have a technical expert contact you to learn more about our analytical solutions? *
  • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.